Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

WAY-317538

From Wikipedia, the free encyclopedia
(Redirected fromWAY-317,538)
Chemical compound
Pharmaceutical compound
WAY-317538
Legal status
Legal status
  • In general: legal
Identifiers
  • 5-Morpholin-4-yl-pentanoic acid (4-pyridin-3-yl-phenyl)-amide
CAS Number
PubChemCID
ChemSpider
UNII
ChEMBL
CompTox Dashboard(EPA)
Chemical and physical data
FormulaC20H25N3O2
Molar mass339.439 g·mol−1
3D model (JSmol)
  • C3COCCN3CCCCC(=O)Nc1ccc(cc1)-c2cccnc2

  • HCl: C1COCCN1CCCCC(=O)NC2=CC=C(C=C2)C3=CN=CC=C3.Cl
  • InChI=1S/C20H25N3O2/c24-20(5-1-2-11-23-12-14-25-15-13-23)22-19-8-6-17(7-9-19)18-4-3-10-21-16-18/h3-4,6-10,16H,1-2,5,11-15H2,(H,22,24) ☒N
  • Key:XCHIZTUBUXZESJ-UHFFFAOYSA-N ☒N

  • HCl: InChI=1S/C20H25N3O2.ClH/c24-20(5-1-2-11-23-12-14-25-15-13-23)22-19-8-6-17(7-9-19)18-4-3-10-21-16-18;/h3-4,6-10,16H,1-2,5,11-15H2,(H,22,24);1H
  • Key:GBMDUJQQSGOIFW-UHFFFAOYSA-N
 ☒NcheckY (what is this?)  (verify)

WAY-317538 (SEN-12333) is a drug that acts as a potent and selectivefull agonist for theα7 subtype of neuralnicotinic acetylcholine receptors. It was not the most potent compound in the series, but was selected for further development on the basis of its high selectivity over related receptors, ease of synthesis, and goodin vivo properties including high oral bioavailability and good brain penetration.[1] It hasnootropic andneuroprotective effects in animal studies, and is being investigated as a potential treatment for neurodegenerative and neurocognitive conditions includingAlzheimer's disease andschizophrenia.[2]

References

[edit]
  1. ^Haydar SN, Ghiron C, Bettinetti L, Bothmann H, Comery TA, Dunlop J, et al. (July 2009). "SAR and biological evaluation of SEN12333/WAY-317538: Novel alpha 7 nicotinic acetylcholine receptor agonist".Bioorganic & Medicinal Chemistry.17 (14):5247–58.doi:10.1016/j.bmc.2009.05.040.PMID 19515567.
  2. ^Roncarati R, Scali C, Comery TA, Grauer SM, Aschmi S, Bothmann H, et al. (May 2009). "Procognitive and neuroprotective activity of a novel alpha7 nicotinic acetylcholine receptor agonist for treatment of neurodegenerative and cognitive disorders".The Journal of Pharmacology and Experimental Therapeutics.329 (2):459–68.doi:10.1124/jpet.108.150094.PMID 19223665.S2CID 6667145.
Adamantanes
Adenosine antagonists
Alkylamines
Ampakines
Arylcyclohexylamines
Benzazepines
Cathinones
Cholinergics
Convulsants
Eugeroics
Oxazolines
Phenethylamines
Phenylmorpholines
Piperazines
Piperidines
Phenethylpyrrolidines
Racetams
Psychedelics
Tropanes
Tryptamines
Others
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(andPAMsTooltip positive allosteric modulators)
Antagonists
(andNAMsTooltip negative allosteric modulators)
Precursors
(andprodrugs)


Stub icon

Thisdrug article relating to thenervous system is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=WAY-317538&oldid=1304692516"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp